EODData

MEMBERSHIP REGISTER LOG IN

FRA, 29A: Amphastar P

25 Sep 2026
LAST:

22.61

CHANGE:
 0.26		OPEN:
22.62		HIGH:
22.62		ASK:
0.00		VOLUME:
0
CHG(%):
1.16		PREV:
22.35		LOW:
22.61		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 Sep 2622.6222.6222.6122.610
24 Sep 2621.3722.3521.3722.350
23 Sep 2620.8021.4920.8021.49100
22 Sep 2620.8521.3820.8521.38100
21 Sep 2620.1521.7220.1521.720
18 Sep 2620.2920.3020.2920.300
17 Sep 2620.5120.5120.5120.510
16 Sep 2620.0220.0220.0220.020
15 Sep 2620.1620.4020.1620.400
14 Sep 2620.0520.6720.0520.670

PROFILE

Name:Amphastar P
About:Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging, as well as Albuterol Sulfate inhalation aerosol. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Sector:Healthcare
Address:11570 6th Street, Rancho Cucamonga, CA, United States, 91730
Website:https://www.amphastar.com
ISIN:US03209R1032
LEI:54930055TH0ZLSAQMJ38

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:12.41 
Forward P/E:12.94 
PEG Ratio:2.73 
Price to Sales:1.06 
Price to Book:1.16 
Profit Margin:0.11 
Operating Margin:0.22 
Return on Assets:0.05 
Return on Equity:0.10 
Revenue:630.24M 
EBITDA:192.86M 
Shares:46.5M 
Market Cap:1.051B 

TECHNICAL INDICATORS

MA5:21.913.2%
MA10:21.156.9%
MA20:20.2411.7%
MA50:18.3423.3%
MA100:17.3330.4%
MA200:18.8220.1%
STO9:99.62 
STO14:99.70 
RSI14:77.30 
MTM14:3.15
ROC14:0.16 
ATR:0.55 
Week High:22.620.0%
Week Low:20.1512.2%
Month High:22.620.0%
Month Low:17.9720.1%
Year High:24.689.2%
Year Low:13.9062.7%